quest medical research ltd Company Information
Company Number
12660425
Next Accounts
Mar 2026
Shareholders
william dowson
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
27 old gloucester street, london, WC1N 3AX
Website
-quest medical research ltd Estimated Valuation
Pomanda estimates the enterprise value of QUEST MEDICAL RESEARCH LTD at £8.9k based on a Turnover of £8k and 1.11x industry multiple (adjusted for size and gross margin).
quest medical research ltd Estimated Valuation
Pomanda estimates the enterprise value of QUEST MEDICAL RESEARCH LTD at £0 based on an EBITDA of £0 and a 4.16x industry multiple (adjusted for size and gross margin).
quest medical research ltd Estimated Valuation
Pomanda estimates the enterprise value of QUEST MEDICAL RESEARCH LTD at £0 based on Net Assets of £-8.7k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Quest Medical Research Ltd Overview
Quest Medical Research Ltd is a live company located in london, WC1N 3AX with a Companies House number of 12660425. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in June 2020, it's largest shareholder is william dowson with a 100% stake. Quest Medical Research Ltd is a young, micro sized company, Pomanda has estimated its turnover at £8k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Quest Medical Research Ltd Health Check
Pomanda's financial health check has awarded Quest Medical Research Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs


2 Strong

1 Regular

4 Weak

Size
annual sales of £8k, make it smaller than the average company (£3.9m)
- Quest Medical Research Ltd
£3.9m - Industry AVG

Growth
There is insufficient data available for this Key Performance Indicator!
- Quest Medical Research Ltd
- - Industry AVG

Production
with a gross margin of 28.5%, this company has a higher cost of product (55.3%)
- Quest Medical Research Ltd
55.3% - Industry AVG

Profitability
an operating margin of 0% make it more profitable than the average company (-10.2%)
- Quest Medical Research Ltd
-10.2% - Industry AVG

Employees
with 1 employees, this is below the industry average (48)
- Quest Medical Research Ltd
48 - Industry AVG

Pay Structure
on an average salary of £81.8k, the company has an equivalent pay structure (£81.8k)
- Quest Medical Research Ltd
£81.8k - Industry AVG

Efficiency
resulting in sales per employee of £8k, this is less efficient (£130.8k)
- Quest Medical Research Ltd
£130.8k - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Quest Medical Research Ltd
- - Industry AVG

Creditor Days
its suppliers are paid after 555 days, this is slower than average (57 days)
- Quest Medical Research Ltd
57 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Quest Medical Research Ltd
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Quest Medical Research Ltd
- - Industry AVG

Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Quest Medical Research Ltd
- - Industry AVG
QUEST MEDICAL RESEARCH LTD financials

Quest Medical Research Ltd's latest turnover from June 2024 is estimated at £8 thousand and the company has net assets of -£8.7 thousand. According to their latest financial statements, we estimate that Quest Medical Research Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
---|---|---|---|---|
Turnover | ||||
Other Income Or Grants | ||||
Cost Of Sales | ||||
Gross Profit | ||||
Admin Expenses | ||||
Operating Profit | ||||
Interest Payable | ||||
Interest Receivable | ||||
Pre-Tax Profit | ||||
Tax | ||||
Profit After Tax | ||||
Dividends Paid | ||||
Retained Profit | ||||
Employee Costs | ||||
Number Of Employees | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
---|---|---|---|---|
Tangible Assets | ||||
Intangible Assets | ||||
Investments & Other | 2 | |||
Debtors (Due After 1 year) | ||||
Total Fixed Assets | 2 | |||
Stock & work in progress | ||||
Trade Debtors | 5,102 | 10,314 | ||
Group Debtors | ||||
Misc Debtors | ||||
Cash | ||||
misc current assets | ||||
total current assets | 5,102 | 10,314 | ||
total assets | 5,102 | 10,314 | 2 | |
Bank overdraft | ||||
Bank loan | ||||
Trade Creditors | 8,671 | 13,773 | 14,285 | |
Group/Directors Accounts | ||||
other short term finances | ||||
hp & lease commitments | ||||
other current liabilities | ||||
total current liabilities | 8,671 | 13,773 | 14,285 | |
loans | ||||
hp & lease commitments | ||||
Accruals and Deferred Income | ||||
other liabilities | ||||
provisions | ||||
total long term liabilities | ||||
total liabilities | 8,671 | 13,773 | 14,285 | |
net assets | -8,671 | -8,671 | -3,971 | 2 |
total shareholders funds | -8,671 | -8,671 | -3,971 | 2 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
---|---|---|---|---|
Operating Activities | ||||
Operating Profit | ||||
Depreciation | ||||
Amortisation | ||||
Tax | ||||
Stock | ||||
Debtors | -5,102 | -5,212 | 10,314 | |
Creditors | -5,102 | -512 | 14,285 | |
Accruals and Deferred Income | ||||
Deferred Taxes & Provisions | ||||
Cash flow from operations | ||||
Investing Activities | ||||
capital expenditure | ||||
Change in Investments | -2 | 2 | ||
cash flow from investments | ||||
Financing Activities | ||||
Bank loans | ||||
Group/Directors Accounts | ||||
Other Short Term Loans | ||||
Long term loans | ||||
Hire Purchase and Lease Commitments | ||||
other long term liabilities | ||||
share issue | ||||
interest | ||||
cash flow from financing | ||||
cash and cash equivalents | ||||
cash | ||||
overdraft | ||||
change in cash |
quest medical research ltd Credit Report and Business Information
Quest Medical Research Ltd Competitor Analysis

Perform a competitor analysis for quest medical research ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in WC1N area or any other competitors across 12 key performance metrics.
quest medical research ltd Ownership
QUEST MEDICAL RESEARCH LTD group structure
Quest Medical Research Ltd has no subsidiary companies.
Ultimate parent company
QUEST MEDICAL RESEARCH LTD
12660425
quest medical research ltd directors
Quest Medical Research Ltd currently has 2 directors. The longest serving directors include Mr William Dowson (Jun 2020) and Hon Elizabeth Barnes-Dowson (Sep 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr William Dowson | United Kingdom | 55 years | Jun 2020 | - | Director |
Hon Elizabeth Barnes-Dowson | United Kingdom | 63 years | Sep 2021 | - | Director |
P&L
June 2024turnover
8k
-44%
operating profit
0
0%
gross margin
28.5%
+6.27%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
-8.7k
0%
total assets
0
-1%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
quest medical research ltd company details
company number
12660425
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
June 2020
age
5
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
June 2024
previous names
N/A
accountant
-
auditor
-
address
27 old gloucester street, london, WC1N 3AX
Bank
-
Legal Advisor
-
quest medical research ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to quest medical research ltd.
quest medical research ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for QUEST MEDICAL RESEARCH LTD. This can take several minutes, an email will notify you when this has completed.
quest medical research ltd Companies House Filings - See Documents
date | description | view/download |
---|